Factors Associated with Periductal Fibrosis Diagnosed by Ultrasonography Screening among a High Risk Population for Cholangiocarcinoma in Northeast Thailand

  • Intajarurnsan, Sutheera (Public Health Program, Faculty of Medicine, Khon Kaen University) ;
  • Khuntikeo, Narong (Department of Surgery, Faculty of Medicine, Khon Kaen University) ;
  • Chamadol, Nittaya (Department of Radiology, Faculty of Medicine, Khon Kaen University) ;
  • Thinkhamrop, Bandit (Department of Epidemiology and Biostatistics, Faculty of Public Health, Khon Kaen University) ;
  • Promthet, Supannee (Department of Epidemiology and Biostatistics, Faculty of Public Health, Khon Kaen University)
  • Published : 2016.08.01


Background: The population in northeast Thailand continues to present with hepatobiliary abnormalities, particularly periductal fibrosis (PDF) which is the result of chronic infection with liver fluke (Opisthorchis viverini; OV) and may lead to the development of cholangiocarcinoma (CCA). Although the prevalence of OV infection has been decreased due to a liver fluke control program over decades, the prevalence of PDF remains high. This study aimed to investigate demographic factors associated with PDF risk based on ultrasonography (US) screening. Materials and Methods: This cross-sectional study is part of the Cholangiocarcinoma Screening and Care Program (CASCAP), a prospective cohort study. Multiple logistic regression was used for data analysis. Results: In 55,246 subjects, the overall prevalence of PDF was 33.0% (95%CI: 32.6 - 33.4). Males (33.9 %) were at higher risk for developing PDF than females (32.2 %) (ORcrude = 0.93; 95%CI: 0.89 - 0.96; p-value < 0.001). Factors associated with an increased PDF risk, in addition to OV infection, included old age (${\geq}70$ years) (ORadj = 1.28, 95% CI: 1.14 - 1.44, p < 0.001) and hepatitis B infection (ORadj = 1.31, 95% CI: 1.11 - 1.55, p = 0.001). In contrast, number of praziquantel treatments (> 2 times) (ORadj = 0.54, 95% CI: 0.47 - 0.63, p < 0.001) and diabetes mellitus (ORadj = 0.57, 95% CI: 0.49 - 0.65, p < 0.001) were significantly associated with a decreased PDF risk. Conclusions: Future US screening should closely examine older people and hepatitis B subjects for the purpose of PDF surveillance among high risk groups for CCA. However, the results of inverse associations require further investigation in order to confirm our findings.


Supported by : National Research Council of Thailand


  1. Benedetti NJ, Desser TS, Jeffrey RB (2008). Imaging of hepatic infections. Ultrasound Q, 24, 267-78.
  2. Chaiteerakij R, Juran BD, Aboelsoud MM, et al (2015). Association between variants in inflammation and cancerassociated genes and risk and survival of cholangiocarcinoma. Cancer Med, 4, 1599-602.
  3. Chaiteerakij R, Yang JD, Harmsen WS, et al (2013). Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatol, 57, 648-55.
  4. Chamadol N, Pairojkul C, Khuntikeo N, et al (2014). Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients. J Hepato-Biliary-Pancreatic Sciences, 21, 316-22.
  5. Charoensuk L, Pinlaor P, Wanichwecharungruang S, et al (2016). Nanoencapsulated curcumin and praziquantel treatment reduces periductal fibrosis and attenuates bile canalicular abnormalities in Opisthorchis viverrini-infected hamsters. Nanomedicine: Nanotechnology, Biol Med, 12, 21-32.
  6. Deerochanawong C, Ferrario A (2013). Diabetes management in Thailand: a literature review of the burden, costs, and outcomes. Globalization Health, 9, 11.
  7. Gatto M, Bragazzi MC, Semeraro R, et al (2010). Cholangiocarcinoma: update and future perspectives. Dig Liver Dis, 42, 253-60.
  8. He L SA, Djedjos S, Miller R, et al (2009). Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell, 137, 635-46.
  9. Incio J, Suboj P, Chin SM, et al (2015). Metformin reduces desmoplasia in pancreatic cancer by reprogramming stellate cells and tumor-associated macrophages. PLoS One, 10, 141392.
  10. Intuyod KPS, Yongvanit P (2012). Molecular carcinogenesis of cholangiocarcinoma: host-liver fluke interaction. Srinagarind Med J, 27, 356-63.
  11. Jaiswal M, LaRusso NF, Burgart LJ, et al (2000). Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res, 60, 184-90.
  12. Jongsuksuntigul P, Imsomboon T (2003). Opisthorchiasis control in Thailand. Acta Trop, 88, 229-32.
  13. Kamsa-ard S LM, Luvira V, Bhudhisawasdi V. ( 2013). Association between praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 14, 7011-6.
  14. Khuhaprema T, Srivatanakul P, Attasara P, et al (2010). Cancer in Thailand Bangkok: Bangkok Medical Publisher, Vol. 2001-2003, 3-76.
  15. Khuntikeo N, Chamadol N, Yongvanit P, et al (2015). Cohort profile: cholangiocarcinoma screening and care program (CASCAP). BMC Cancer, 15, 459.
  16. Lan T, Chang L, Wu L, et al (2015). IL-6 Plays a Crucial Role in HBV Infection. J Clin Translational Hepatology, 3, 271-6.
  17. Mairiang E, Laha T, Bethony JM, et al (2012). Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand. Parasitol Int, 61, 208-11.
  18. Moore MA, Attasara P, Khuhaprema T, et al (2010). Cancer Epidemiology in Mainland South-East Asia - Past, Present and Future. Asian Pac J Cancer Prev, 11, 67-80.
  19. Pinlaor S, Prakobwong S, Boonmars T, et al (2009). Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection. Acta Tropica, 111, 181-91.
  20. Poomphakwaen K, Promthet S, Kamsa-Ard S, et al (2009). Risk factors for cholangiocarcinoma in Khon Kaen, Thailand: a nested case-control study. Asian Pac J Cancer Prev, 10, 251-8.
  21. Rizvi S, Gores GJ (2013). Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterol, 145, 1215-29.
  22. Saengsawang P, Promthet S, Bradshaw P (2013). Infection with Opisthorchis viverrini and use of praziquantel among a working-age population in Northeast Thailand. Asian Pac J Cancer Prev, 14, 2963-6.
  23. Saengsawang P, Promthet S, Bradshaw P (2016). Reinfection by Opisthorchis viverrini after treatment with praziquantel. Asian Pac J Cancer Prev, 17, 857-62.
  24. Shaib Y, El-Serag HB (2004). The epidemiology of cholangiocarcinoma. Semin Liver Dis, 24, 115-25.
  25. Shaib YH, El-Serag HB, Nooka AK, et al (2007). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol, 102, 1016-21.
  26. Shin HR, Oh JK, Masuyer E, et al (2010). Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci, 101, 579-85.
  27. Sithithaworn P, Yongvanit P, Duenngai K, et al (2014). Roles of liver fluke infection as risk factor for cholangiocarcinoma. J Hepatobiliary Pancreat Sci, 21, 301-8.
  28. Songserm N, Promthet S, Sithithaworn P, et al (2012). Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms. Cancer Epidemiol, 36, e89-94.
  29. Songserm N, Promthet S, Pientong C, et al (2014). Geneenvironment interaction involved in cholangiocarcinoma in the Thai population: polymorphisms of DNA repair genes, smoking and use of alcohol. BMJ Open, 4, 5447.
  30. Sripa B, Brindley PJ, Mulvenna J, et al (2012a). The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer. Trends Parasitol, 28, 395-407.
  31. Sripa B, Mairiang E, Thinkhamrop B, et al (2009). Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6. Hepatol, 50, 1273-81.
  32. Sripa B, Pairojkul C (2008). Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol, 24, 349-56.
  33. Sripa B, Thinkhamrop B, Mairiang E, et al (2012b). Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini. PLoS Negl Trop Dis, 6, 1654.
  34. StataCorp LP (2007). Stata Release 10: User's guide. College Station TX: Stata Press.
  35. Thaewnongiew K, Singthong S, Kutchamart S, et al (2014). Prevalence and risk factors for Opisthorchis viverrini infections in upper Northeast Thailand. Asian Pac J Cancer Prev, 15, 6609-12.
  36. Thinkhamrop K, Khuntikeo N, Phonjitt P, et al (2015). Association between diabetes mellitus and fatty liver based on ultrasonography screening in the world’s highest cholangiocarcinoma incidence region, Northeast Thailand. Asian Pac J Cancer Prev, 16, 3931-36.
  37. Watanapa P, Watanapa WB (2002). Liver fluke-associated cholangiocarcinoma. Br J Surg, 89, 962-70.
  38. Welzel TM, Graubard BI, El-Serag HB, et al (2007). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol, 5, 1221-8.
  39. Yeoh KW, Promthet S, Sithithaworn P, et al (2015). Reexamination of Opisthorchis viverrini infection in Northeast Thailand. Asian Pac J Cancer Prev, 16, 3413-8.
  40. Zhang H, Yang T, Wu M, et al (2016). Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management. Cancer Lett, 379, 198-205.